摘要 |
The present invention provides a polynucleotide (snpg) initially isolated from a colon cDNA library which identifies and encodes a novel human synaptogyrin homolog (SNPG). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding SNPG. The invention also provides for the use of SNPG in the membrane of a vesicle containing a chemical or biological therapeutic composition for the treatment of disease, and for the therapeutic use of antisense molecules, antibodies, antagonists or inhibitors in the treatment of conditions or diseases associated with the abnormal or excess expression of SNPG. The invention also describes diagnostic assays which utilize diagnostic compositions comprising the polynucleotide, fragments or the complement thereof, which hybridize with the genomic sequence or the transcript of snpg, or anti-SNPG antibodies which specifically bind to the polypeptide SNPG.
|
申请人 |
INCYTE PHARMACEUTICALS, INC.;HAWKINS, PHILLIP, R.;STUART, SUSAN, G.;MURRY, LYNN, E. |
发明人 |
HAWKINS, PHILLIP, R.;STUART, SUSAN, G.;MURRY, LYNN, E. |